Dr David Atkins, CEO of Congenica speaks on the life sciences ecosystem in the UK and Congenica’s part to play therein. Dr Atkins speaks on the scope and scale of Congenica’s operations, their ambitions to develop further the company, as well as the challenges that Congenica and the industry at large face in the shifting healthcare and pharmaceutical landscape.
Read the full article here.
In recognition of Rare Disease Day, Congenica looks at the importance of a genetic diagnosis for patients and asks, what's next for rare disease?
For International Day of Women and Girls in Science, we talk to three women at Congenica about their experiences of working in STEM.
Professor Matthew Hurles, project lead for DDD study and Congenica founder, discsuses his projects, advancements in data analysis and interpretation